Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill

[SonofBen]

Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.

But the drugmaker posted mixed fourth-quarter results, beating on earnings but missing on revenue.

Pfizer forecasts $98 billion to $102 billion in sales for 2022, and adjusted earnings per share of $6.35 to $6.55.

On an unadjusted basis, fourth-quarter profit soared more than fourfold to $3.39 billion.


https://www.cnbc.com/2022/02/08/covid-pfizer-pfe-earnings-q4-2021.html

[Hoyt]

1. Worth every penny, IMO.

[SonofBen]

5. Especially if you bought the stock

Knowing that the government was going to purchase large quantities of the drugs to distribute for free.

But that would be insider trading, which of course is illegal.

Usually.

[Tomconroy]

2. Pfizer is one of the few heros of the pandemic.

[NQAS]

3. I would like to see

Pfizer using done of those profits to supply vaccines at little or no cost to less developed countries.

[VarryOn]

4. I hope they can get the therapeutic antiviral made and distributed in vast quantities soon...

If it works as well as the tests have shown, we should be set. A vaccine plus a supereffective therapeutic should assuage a lot of fear.